- Home
- GLPG vs EVT Comparison
GLPG vs EVT Comparison
Compare GLPG & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- EVT
- Stock Information
- Founded
- GLPG 1999
- EVT 2003
- Country
- GLPG Belgium
- EVT United States
- Employees
- GLPG N/A
- EVT N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- GLPG Health Care
- EVT Finance
- Exchange
- GLPG Nasdaq
- EVT Nasdaq
- Market Cap
- GLPG 1.8B
- EVT 1.6B
- IPO Year
- GLPG 2005
- EVT N/A
- Fundamental
- Price
- GLPG $26.49
- EVT $22.05
- Analyst Decision
- GLPG Sell
- EVT
- Analyst Count
- GLPG 4
- EVT 0
- Target Price
- GLPG $25.33
- EVT N/A
- AVG Volume (30 Days)
- GLPG 389.2K
- EVT 182.2K
- Earning Date
- GLPG 04-23-2025
- EVT 01-01-0001
- Dividend Yield
- GLPG N/A
- EVT 8.95%
- EPS Growth
- GLPG N/A
- EVT N/A
- EPS
- GLPG N/A
- EVT 6.63
- Revenue
- GLPG $311,493,731.00
- EVT $69,404,302.00
- Revenue This Year
- GLPG $0.08
- EVT N/A
- Revenue Next Year
- GLPG $0.23
- EVT N/A
- P/E Ratio
- GLPG N/A
- EVT $3.26
- Revenue Growth
- GLPG 18.32
- EVT N/A
- 52 Week Low
- GLPG $22.36
- EVT $19.20
- 52 Week High
- GLPG $31.23
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- GLPG 65.43
- EVT 49.77
- Support Level
- GLPG $24.31
- EVT $20.56
- Resistance Level
- GLPG $24.91
- EVT $22.24
- Average True Range (ATR)
- GLPG 0.83
- EVT 0.94
- MACD
- GLPG 0.27
- EVT 0.08
- Stochastic Oscillator
- GLPG 95.59
- EVT 93.44
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.